GGrantIndex
← Leaderboards

Ivelin Georgiev

Vanderbilt University Medical Center

$12,025,888
Attributed
$12,025,888
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.4M · FY201725
$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,025,888 · 7

By mechanism

R01$10,430,579 · 3
R21$902,000 · 2
U19$693,309 · 2

Top collaborators

No co-investigators on record.

Most similar at Vanderbilt University Medical Center

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Antibody Response

Research focus

Antibody ResponseEpitopesAntibodiesAntigensTechnologyHiv-1SpecificityImmune SystemInfectionB-LymphocytesSamplingPathogenVaccine DesignValidationScreeningGenerationsLinkCellsEpitope MappingVaccinesComplexResponseB-Cell Antigen ReceptorLibraries

Grant awards (21)

Technologies for High-Throughput Mapping of Antigen Specificity to B-Cell-Receptor Sequence$841,663
R01 · FY2025 · AI · contact PI
Core 3: Single-Cell Core$225,199
U19 · FY2025 · AI · contact PI
Technologies for High-Throughput Mapping of Antigen Specificity to B-Cell-Receptor Sequence$841,663
R01 · FY2024 · AI · contact PI
Core 3: Single-Cell Core$239,285
U19 · FY2024 · AI · contact PI
Technologies for High-Throughput Mapping of Antigen Specificity to B-Cell-Receptor Sequence$841,663
R01 · FY2023 · AI · contact PI
High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals$823,824
R01 · FY2023 · AI · contact PI
Core 3: Single-Cell Core$228,825
U19 · FY2023 · AI · contact PI
High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals$857,109
R01 · FY2022 · AI · contact PI
High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals$859,004
R01 · FY2021 · AI · contact PI
Antibody repertoire characterization in the context of coronaviruses$673,335
R01 · FY2021 · AI · contact PI
Neutralization Fingerprinting Analysis of Polyclonal Antibody Responses against HIV-1$610,412
R01 · FY2021 · AI · contact PI
High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals$879,020
R01 · FY2020 · AI · contact PI
Antibody repertoire characterization in the context of coronaviruses$675,447
R01 · FY2020 · AI · contact PI
Neutralization Fingerprinting Analysis of Polyclonal Antibody Responses against HIV-1$617,708
R01 · FY2020 · AI · contact PI
Multivalent nanoparticle platforms for elicitation of broadly neutralizing HIV-1 antibodies$255,000
R21 · FY2020 · AI · contact PI
Neutralization Fingerprinting Analysis of Polyclonal Antibody Responses against HIV-1$625,626
R01 · FY2019 · AI · contact PI
Design of immunogens for elicitation of neutralizing antibody responses against Zika virus$237,000
R21 · FY2019 · AI · contact PI
Multivalent nanoparticle platforms for elicitation of broadly neutralizing HIV-1 antibodies$212,500
R21 · FY2019 · AI · contact PI
Neutralization Fingerprinting Analysis of Polyclonal Antibody Responses against HIV-1$633,392
R01 · FY2018 · AI · contact PI
Design of immunogens for elicitation of neutralizing antibody responses against Zika virus$197,500
R21 · FY2018 · AI · contact PI
Neutralization Fingerprinting Analysis of Polyclonal Antibody Responses against HIV-1$650,713
R01 · FY2017 · AI · contact PI